SEGMENT INFORMATION (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Revenue	$ 34,131	$ 89,600	$ 223,621	$ 135,774
(Loss) income from operations	(105,775)	(32,774)	(406,308)	(310,469)
Interest expense	(69,601)	(50,362)	(201,229)	(242,626)
Net loss (gain) on derivative liability	$ (48,751)	52,977	(132,614)	(337,132)
Gain on forgiveness and modification of debt		$ 325,335	7,900	$ 4,032,608
Gain on sale of equipment	$ 50,000		$ 50,000
Provision for reserve on receivable due from MJ Enterprises		$ (100,000)		$ (100,000)
Net income (loss)	$ (174,127)	195,176	$ (682,251)	3,042,381
Assets	148,337	145,113	148,337	145,113	$ 309,940
Nanotechnology Segment [Member]
Revenue	24,371	89,600	131,652	135,774
(Loss) income from operations	(53,472)	(32,774)	(373,168)	(310,469)
Interest expense	(69,601)	(50,362)	(201,229)	(242,626)
Net loss (gain) on derivative liability	$ (48,751)	52,977	(132,614)	(337,132)
Gain on forgiveness and modification of debt		$ 325,335	7,900	$ 4,032,608
Gain on sale of equipment	$ 50,000		$ 50,000
Provision for reserve on receivable due from MJ Enterprises		$ (100,000)		$ (100,000)
Net income (loss)	$ (121,824)	195,176	$ (649,111)	3,042,381
Assets	32,817	$ 145,113	32,817	$ 145,113
Viralprotec Segment [Member]
Revenue	9,760		91,969
(Loss) income from operations	$ (52,303)		$ (33,140)
Interest expense
Net loss (gain) on derivative liability
Gain on forgiveness and modification of debt
Gain on sale of equipment
Provision for reserve on receivable due from MJ Enterprises
Net income (loss)	$ (52,303)		$ (33,140)
Assets	$ 115,520		$ 115,520